MorphoSys, Bristol-Myers Squibb Extend Cooperation

German biotech MorphoSys AG is expanding its existing license agreement with Bristol-Myers Squibb. Under the amended agreement, MorphoSys grants Bristol-Myers Squibb access to its HuCAL GOLD library for use in Bristol-Myers Squibb's pharmaceutical discovery programs for target characterization and validation, as well as for therapeutic and diagnostic antibody product development. Financial details were not disclosed.

iWon (http://money.iwon.com/jsp/nw/nwdt_rt.jsp?cat=USMARKET&src=704&feed=dji§ion=news&news_id=dji-00034420050126&date=20050126&alias=/alias/money/cm/nw)